ProfileGDS5822 / ILMN_1234193
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 7% 23% 14% 8% 29% 33% 1% 11% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 18.77
GSM1276600PDAC Late Ablation Control 215.623
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.914
GSM1276603PDAC Late Ablation 27.58
GSM1276604PDAC Late Ablation 315.329
GSM1303940PDAC Late Ablation_anti-CTLA4 116.333
GSM1303941PDAC Late Ablation_anti-CTLA4 21.21
GSM1303942PDAC Late Ablation_anti-CTLA4 37.111